SYNERGY MEGATRON™ H7493942812450Recalls & reported problems
Boston Scientific Corporation · Everolimus-Eluting Platinum Chromium Coronary Stent System · Class 3 · Implant
All models of SYNERGY MEGATRON (28)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 08714729985594), received between Dec 14, 2021 and Jun 25, 2025 — classified as 1 injury, 5 malfunctions.
The most frequently reported specific device problem is “Difficult to Remove” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Difficult to Remove4
- Break3
- Adverse Event Without Identified Device or Use Problem1
- Deflation Problem1
- Failure to Deflate1
- Material Integrity Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions6
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
MalfunctionJun 25, 2025Break; Break
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. A 4.50 X 12MM SYNERGY MEGATRON? DRUG-ELUTING STENT WAS ADVANCED FOR TREATMENT. AFTER THE STENT WAS DEPLOYED, THE STENT DELIVERY SYSTEM AND THE WIRE WERE REMOVED. HOWEVER, THE DISTAL SHAFT WAS FOUND TO BE BROKEN WHILE THE WIRE WAS STILL INTACT. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22330795 ↗MalfunctionFeb 13, 2024Break; Difficult to Remove; Break; Difficult to Remove
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. A 4.50 X 12MM SYNERGY MEGATRON DRUG-ELUTING STENT WAS DEPLOYED FOR TREATMENT. HOWEVER, UPON REMOVAL, THE STENT BALLOON GOT LODGED IN THE GUIDE AND THE SHAFT BROKE AT POLYMER TRANSITION. THE DEVICE AND THE GUIDE CATHETER WERE REMOVED, AND THE PROCEDURE WAS COMPLETED WITH NO PATIENT COMPLICATIONS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18695983 ↗MalfunctionApr 25, 2023Failure to Deflate; Failure to Deflate
IT WAS REPORTED THAT DEFLATION FAILURE OCCURRED. A 4.50 X 12MM SYNERGY MEGATRON DRUG-ELUTING STENT WAS ADVANCED AND DEPLOYED TO TREAT THE LESION. HOWEVER, DURING DEFLATION OF THE BALLOON, IT WAS FAILED TO DEFLATE DESPITE OF MULTIPLE ATTEMPTS. THE BALLOON HAD TO BE PULLED OUT TOGETHER WITH THE WIRE AND THE PROCEDURE WAS COMPLETED. THERE WERE NO PATIENT COMPLICATIONS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16808937 ↗MalfunctionApr 12, 2023Difficult to Remove; Material Integrity Problem; Difficult to Remove; Material Integrity Problem
IT WAS REPORTED THAT STENT DELIVERY SYSTEM REMOVAL DIFFICULTIES OCCURRED. THE TARGET LESION WAS LOCATED IN THE PROXIMAL LEFT ANTERIOR DESCENDING (LAD) ARTERY. A 4.50 X 12MM SYNERGY MEGATRON DRUG-ELUTING STENT WAS ADVANCED AND SUCCESSFULLY IMPLANTED IN THE LESION. HOWEVER, THE PHYSICIAN STRUGGLED TO REMOVE THE STENT DELIVERY SYSTEM (SDS) FROM THE FRESHLY DEPLOYED STENT. IT WAS NOTICED THAT THE DISTAL PLASTIC OF THE SHAFT WAS STRETCHED AND BECAME ELONGATED DURING THE REMOVAL. THE SDS WAS ABLE TO REMOVE INTACT AFTER EXERTING SIGNIFICANT AND MORE WITHDRAWAL FORCE AND THE PROCEDURE WAS COMPLETED. THERE WERE NO PATIENT COMPLICATIONS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16724185 ↗InjuryJul 26, 2022Break; Difficult to Remove; Adverse Event Without Identified Device or Use Problem; Break; Difficult to Remove; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. THE 90% STENOSED TARGET VESSEL WAS LOCATED IN THE MODERATELY CALCIFIED AND MILDLY TORTUOUS LEFT MAIN ARTERY. A 4.5MM X 12MM SYNERGY MEGATRON DRUG-ELUTING STENT WAS SUCCESSFULLY IMPLANTED, HOWEVER, THE STENT DELIVERY SYSTEM WAS DIFFICULT TO REMOVE FROM THE STENT. FORCEFUL REMOVAL WAS REQUIRED AND THE CATHETER FRACTURED. AN ATTEMPT TO REMOVE THE FRACTURED CATHETER VIA SNARE WAS UNSUCCESSFUL AND THE DEVICE HAD TO BE REMOVED BY A VASCULAR SURGEON USING A CUTDOWN OF THE BRACHIAL ARTERY. THE PROCEDURE WAS COMPLETED SUCCESSFULLY. HOSPITAL ADMISSION BEYOND STANDARD OF CARE WAS REQUIRED, HOWEVER, THE PATIENT IS FULLY RECOVERED. THERE WERE NO FURTHER COMPLICATIONS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15106088 ↗MalfunctionDec 14, 2021Deflation Problem; Difficult to Remove; Deflation Problem; Difficult to Remove
IT WAS REPORTED THAT DIFFICULT TO REMOVE A BALLOON OCCURRED. A 100% STENOSED TARGET LESION WAS LOCATED IN THE NONE TORTUOUS AND MILDLY CALCIFIED LEFT MAIN ARTERY. A 4.50 X 12MM SYNERGY MEGATRON STENT WAS SELECTED FOR PERCUTANEOUS CORONARY INTERVENTION (PCI) PROCEDURE. THE DEVICE WAS ADVANCED TO THE TARGET LESION AND DEPLOYED WITHOUT ANY PROBLEMS. THE STENT WAS DEPLOYED AT 11 ATMOSPHERES WITH NO ISSUES ENCOUNTERED. THE STENT WAS POST DILATED AT 16 ATMOSPHERES. WHILE WITHDRAWING BALLOON INTO THE GUIDE CATHETER, RESISTANCE OCCURRED. AFTER SEVERAL ATTEMPTS TO DEFLATE THE MEGATRON STENT BALLOON, THE BALLOON BECAME LODGED IN THE NON-BOSTON SCIENTIFIC GUIDE CATHETER AND IT WOULD NOT COME OUT. THE BALLOON WAS FULLY DEFLATED , THE PHYSICIAN REMOVED THE GUIDE CATHETER AND THE STENT BALLOON AS ONE PIECE BY PULLING THE GUIDE CATHETER WITH IT. THE PROCEDURE WAS COMPLETED SUCCESSFULLY WITH ANOTHER GUIDE CATHETER. THERE WERE NO PATIENT COMPLICATIONS AND THE PATIENT WAS STABLE POST PROCEDURE WITH SUCCESSFUL OUTCOME.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13006773 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page